**Author details**

Olga V. Petyunina\*, Mykola P. Kopytsya, Iurii S. Rudyk and Ganna S. Isayeva Government Institution "L.T. Malaya Therapy National Institute of NAMS of Ukraine", Kharkiv, Ukraine

\*Address all correspondence to: o\_petyunina@ukr.net

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**131**

*Promising Role of Vascular Endothelial Growth Factor-A in Risk Stratification after PCI*

myocardial infarction. Evidence for its origin and functional significance. Journal of Molecular and Cellular Cardiology. 2000;**32**(1):65-72. DOI:

[9] Sant'Anna RT, Kalil RAT, Moreno P, Anflor LCJ, Correa DLC, Ludwig R, et al. Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction. Brazilian Journal of Cardiovascular Surgery. 2003. Print version ISSN 0102-7638; On-line version ISSN 1678-9741. DOI: 10.1590/

10.1006/jmcc.1999.1062

S0102-76382003000200006

[10] Wang B, Cheheltani R, Rosano J, Crabbe DL, Kiani MF. Targeted delivery of VEGF to treat myocardial infarction. Advances in Experimental Medicine and Biology. 2013;**765**:307-314. DOI: 10.1007/978-1-4614-4989-8\_43

[11] Zentilin L, Puligadda U, Lionetti V,

Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. The FASEB Journal. 2010;**24**(5): 1467-1478. DOI: 10.1096/fj.09-143180

Zacchigna S, Collesi C, et al.

(Epub Dec 17, 2009)

[12] Kimura K, Hashiguchi T, Deguchi T, et al. Serum VEGF—As a prognostic factor of atherosclerosis. Atherosclerosis. 2007;**194**(1):182-188. DOI: 10.1016/j.

atherosclerosis.2006.07.025

(Epub Sep 2, 2004)

[13] Moreno P, Purushothaman KR, Fuster V, Echeverri D, Truszczynska E, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta. Circulation. 2004;**110**(14):2032-2038. DOI: 10.1161/01.CIR.0000143233.87854.23

[14] Lin TH, Yen HW, Su HM, Chien WT, Lu YH, Voon WC, et al. Effects

*DOI: http://dx.doi.org/10.5772/intechopen.82712*

morfofunkcionalnoe sostoyanie miokarda u krys pri eksperimentalnom infarkte miokarda. Rossijskij kardiologicheskij zhurnal—Russian Cardiology journal.

[2] Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Reviews.

[3] Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacological Reviews. 2004;**56**(4):549-580. DOI:

[1] Sisakyan AS, Oganyan VA, Semerdzhyan AB, Petrosyan MV, Sisakyan SA, Gurevich MA. Vliyanie faktora angiogeneza na

**References**

2008;**2**:63-66 (in russ)

1997;**18**:527-543

10.1124/pr.56.4.3

mbc.E09-07-0590

ATVBAHA.108.179663

55 (in russ)

2014;**1**(3) id1013

[4] Ferrara N. Binding to the

extracellular matrix and proteolytic processing. Two key mechanisms regulating vascular endothelial growth factor action. Molecular Biology of the Cell. 2010;**21**(5):687-690. DOI: 10.1091/

[5] Ferrara N. Vascular endothelial growth factor. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;**29**(6):789-791. DOI: 10.1161/

[6] Starostin IV, Talitskiy KA, Bulkina OS, Parfenova EV. Karpov YuA collateral blood flow in the myocardium: The role of endothelial growth factor. Kardiologiia—Cardiology. 2012;**11**:49-

[7] Berezin AE. Predicitive role of circulating vascular endothelial growth factor-1 in patients with cardiovascular diseases. Journal of Disease Markers.

[8] Kranz A, Rau C, Kochs M, et al. Elevation of vascular endothelial growth factor-A serum levels following acute

*Promising Role of Vascular Endothelial Growth Factor-A in Risk Stratification after PCI DOI: http://dx.doi.org/10.5772/intechopen.82712*
